BNTX

BioNTech SE

Price

$98.41

return (12m)

p/e

-16.22

p/bv

1.09

DIVIDEND YIELD

0.00%

BNTX price

BioNTech

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment BNTX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals BNTX

Valuation

P/E

-16.22

Sector -4.15

Industry -4.15

P/BV

1.09

Sector 2.06

Industry 2.06

P/Revenue (PSR)

7.17

Sector -4.16

Industry -4.16

EV/EBITDA

-13.08

Sector -241.86

Industry -241.86

EV/EBIT

-10.27

Sector -671.75

Industry -671.75

P/EBITDA

-39.27

Sector -4.30

Industry -4.30

P/EBIT

-20.70

Sector -4.35

Industry -4.35

P/Total Assets

0.97

Sector 1.46

Industry 1.46

P/Net Current Assets

1.55

Sector -12.67

Industry -12.67

P/Working Capital

1.48

Sector -12.58

Industry -12.58

EPS

-5.74

Sector -2.19

Industry -2.19

BVPS

85.44

Sector 1.92

Industry 1.92

Efficiency

Gross Margin

77.61%

Sector 36.44%

Industry 36.44%

EBITDA Margin

-374.94%

Sector -16,748.51%

Industry -16,748.51%

EBIT Margin

-477.65%

Sector -4,256,846.44%

Industry -4,256,846.44%

Operating Margin

-27.08%

Sector -38.78%

Industry -38.78%

Net Profit Margins

-44.22%

Sector -39.93%

Industry -39.93%

Asset Turnover

0.01

Sector 0.03

Industry 0.03

Profitability

ROE

-6.72%

Sector -67.01%

Industry -67.01%

ROA

-5.96%

Sector -66.28%

Industry -66.28%

ROIC

-35.21%

Sector -2,917.75%

Industry -2,917.75%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

8.80

Sector 2.90

Industry 2.90

Net Debt / EBITDA

32.91

Sector -12,252,405.04

Industry -12,252,405.04

Net Debt / EBIT

25.83

Sector -3.79

Industry -3.79

Net Debt / Equity

-0.78

Sector -33,290.93

Industry -33,290.93

Gross Debt / Equity

0.00

Sector 0.00

Industry 0.00

Equity/Assets

0.89

Sector 0.42

Industry 0.42

Liabilities/Assets

0.11

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

-31.80%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals BNTX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
BNTX BioNTech SE	$98.41	1.96%	0.00%	-16.22	1.09	-6.72%	-44.22%
AZN AstraZeneca PLC	$204.64	53.45%	1.89%	25.20	5.52	21.93%	17.19%
JNJ Johnson & Johnson	$240.16	62.69%	2.08%	28.83	0.00	-%	21.48%
ABEO Abeona Therapeutics Inc.	$5.19	12.83%	0.00%	6.09	2.78	45.63%	100.00%
ABUS Arbutus Biopharma Corporation	$4.35	38.54%	0.00%	5.66	3.50	61.77%	83.94%
PFE Pfizer Inc.	$27.11	32.71%	6.97%	18.76	1.55	8.29%	11.83%
NBIX Neurocrine Biosciences Inc.	$130.81	43.95%	0.00%	25.46	5.00	19.62%	21.55%
ABBV AbbVie Inc.	$210.26	25.08%	2.61%	125.53	-69.01	-54.98%	5.79%
ACAD ACADIA Pharmaceuticals Inc.	$22.02	51.03%	0.00%	11.55	3.48	30.10%	34.30%
ADMA ADMA Biologics Inc.	$10.49	-45.93%	0.00%	12.58	5.33	42.37%	32.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

BNTX Historical Dividends

current DY: 0.00%

5-year average DY: 0.35%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	06/03/2022	06/17/2022	2.11100000

ABOUT BioNTech

BioNTech SE

Average Investor10 user rating

4.0 (0 people)

States of America

18 years

Founded: 2008

2019

Time since IPO - 7 years

1.300

Employees

BioNTech SE (States of America) is listed on the Nasdaq and has a market capitalization of $23.54 billion, with shareholders equity totaling $21.62 billion.

The company employs approximately 1.300 people and operates in the Healthcare sector, within the Biotecnologia industry.

Over the past 12 months, BioNTech SE reported $3.28 billion in revenue, generating net income of $-1.45 billion.

Key financial metrics include a P/E ratio of -16.22, a price-to-book (P/B) ratio of 1.09, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BNTX.

Market cap

$23.54 billion

Net worth

$21.62 billion

$21,615,950,000.00

Assets

$24.36 billion

$24,363,120,000.00

Total Shares Outstanding

253.00 million

253,000,000

Average Daily Trading Volume

$996.15 Thousand

$996,151.76

Sector

Healthcare

Industry

Biotecnologia

BNTX

BNTX revenue and profits

Financial Results BNTX

DRAG THE FRAME TO SEE MORE DATA

BNTX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$862.96 22,54% (12M)

P/E

21.66

0.39%

ROE

-570.98%

P/BV

-123.68

CAH - Cardinal Health

$214.95 38,63% (12M)

P/E

34.90

0.89%

ROE

-58.20%

P/BV

-20.31

JNJ - Johnson & Johnson

$240.16 47,25% (12M)

P/E

28.83

2.08%

ROE

P/BV

0.00

MRK - Merck & Co.

$119.96 46,43% (12M)

P/E

35.53

2.62%

ROE

19.45%

P/BV

6.91

AZN - AstraZeneca

$204.64 40,78% (12M)

P/E

25.20

1.89%

ROE

21.93%

P/BV

5.52

ABBV - AbbVie

$210.26 15,08% (12M)

P/E

125.53

2.61%

ROE

-54.98%

P/BV

-69.01

NVO - Novo Nordisk

$39.32 --40,26% (12M)

P/E

11.83

3.68%

ROE

60.40%

P/BV

7.14